How Does TRIPS Address the Balance Between Innovation and Access?
The TRIPS Agreement includes flexibilities that allow countries to tailor the implementation of its standards to their own needs, particularly in public health emergencies. These flexibilities are crucial in finding a balance between encouraging innovation in cancer treatment and ensuring that life-saving drugs are accessible to those in need. The Doha Declaration on the TRIPS Agreement and Public Health reaffirmed WTO members' rights to use these flexibilities to protect public health and promote access to medicines for all.
